Product Images Glipizide And Metformin Hcl

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Glipizide And Metformin Hcl NDC 70518-1594 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Glipizide/Metformin HCI is a medication available in tablet form, with a strength of 5mg/500mg. This particular package contains 180 tablets. The NDC number for this medication is 70518-1594-00, and it is manufactured by Avet Pharmaceuticals Inc., located in East Brunswick, NdJ 08816. The expiration date is not available. The package does not have a LOT number specified. The source NDC for this medication is 23155-0117-01. The tablets have been repackaged by RemedyRepack Inc., located in Indiana, PA 15701. It is important to keep this medication out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-26°C (63-77°F), with excursions permitted between 15-30°C (59-86°F) as per USP guidelines.*

ee5fdf68 df2d 4965 8224 2c2df30f2f22 01

ee5fdf68 df2d 4965 8224 2c2df30f2f22 01

ee5fdf68 df2d 4965 8224 2c2df30f2f22 02

ee5fdf68 df2d 4965 8224 2c2df30f2f22 02

ee5fdf68 df2d 4965 8224 2c2df30f2f22 03

ee5fdf68 df2d 4965 8224 2c2df30f2f22 03

ee5fdf68 df2d 4965 8224 2c2df30f2f22 04

ee5fdf68 df2d 4965 8224 2c2df30f2f22 04

ee5fdf68 df2d 4965 8224 2c2df30f2f22 05

ee5fdf68 df2d 4965 8224 2c2df30f2f22 05

ee5fdf68 df2d 4965 8224 2c2df30f2f22 06

ee5fdf68 df2d 4965 8224 2c2df30f2f22 06

The given text provides information on the number (%) of patients experiencing different adverse events while taking various medications. It includes data on the occurrence of adverse events for different medications, such as Glipizide (5 mg), Metformin (500 mg), Glipizide and Metformin HCI (2.5 mg/250 mg), and Glipizide and Metformin HCI (2.5 mg/500 mg) tablets. Adverse events mentioned in the text include upper respiratory infection, diarrhea, dizziness, hypertension, and nausea/vomiting. The number of patients experiencing each adverse event is provided in parentheses.*

ee5fdf68 df2d 4965 8224 2c2df30f2f22 07

ee5fdf68 df2d 4965 8224 2c2df30f2f22 07

glipiZIDE metFORMIN HCl 5mg 500mg 70518 1594 01

glipiZIDE metFORMIN HCl 5mg 500mg 70518 1594 01

This text appears to be the description of a medication called glipizide/metformin HCI. The tablet contains 5mg of glipizide and 500mg of metformin. The quantity is 90 tablets. The NDC number is 70518-1594-01. The manufacturer is Avet Pharmaceuticals Inc. located in East Brunswick, NDJ 08816. The medication should be kept out of the reach of children. The directions for use can be found in the package insert. The medication should be stored at a temperature of 20-26°C (63-77°F), with excursions permitted between 15-30°C (59-86°F). The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701, with a contact number of 724.466.8762.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.